Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2018 Earnings Conference Call Transcript

Nov 07, 2018 • 04:30 pm ET

Previous

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2018 Earnings Conference Call Transcript

Share
Close

Loading Event

Loading Transcript

Presentation
Operator
Operator

Good day, ladies and gentlemen, and welcome to Arbutus Biopharma Corporation 2018 Third Quarter Financial Results and Corporate Update. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference. Ms. Pam Murphy, you may begin.

Executive
Pam Murphy

Thank you, and good afternoon. Thank you all for joining us. With me today are Dr. Mark Murray, Arbutus' CEO; Dr. Mike Sofia, Arbutus' Chief Scientific Officer; David Hastings, Arbutus' CFO and, Koert VandenEnden, Arbutus' CAO. (Forward-Looking Cautionary Statements) I'd now like to pass the call to Mark for his introductory remarks. Mark?